CJC 1295 and Ipamorelin

What are CJC 1295 and Ipamorelin?

CJC 1295 is a synthetic growth hormone‑releasing hormone (GHRH) analogue that stimulates the pituitary gland to produce more growth
hormone. It has an extended half‑life, meaning it remains active in the body for several days after injection.

Ipamorelin is a selective growth hormone secretagogue.

Unlike older secretagogues such as GHRP‑2 or GHRP‑6, Ipamorelin&#8217

Late Effects of Cancer Treatment

Cancer treatment has evolved dramatically over the past decades,
offering patients improved survival rates and better quality of life during therapy.
However, many survivors experience lingering health challenges long after their initial treatment ends.
These late effects can arise months or even years later, influencing physical function, emotional well‑being, and overall longevity.
Understanding, monitoring, and mana

Call Us

If you have questions about Ipamorelin therapy or would like to schedule a consultation, please call our office during
business hours. Our knowledgeable staff are ready to assist you and provide personalized information tailored to your health goals.

Email Us

For detailed inquiries, medical records requests, or general feedback,
send an email to our support team. We strive to respond
promptly and ensure that all c

Let’s Stay In Touch

Stay connected for updates on peptide therapies, new research findings, and
personalized wellness plans. Join our community through newsletters, webinars, and social media channels to
receive expert insights directly in your inbox.

Shopping cart

When you decide to explore CJC‑1295 and Ipamorelin treatments, you can add the appropriate peptide kits or consultation packa